Observational studyCritical care (London, England)2019
Expiratory flow limitation in intensive care: prevalence and risk factors.
Observational study in Critical care (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 38 citations in OpenAlex.
- Expiratory time constants in mechanically ventilated patients: rethinking the old concept-a narrative review.Intensive care medicine experimental · 2025Review
- Estimated Plasma Volume Status and the Risk of in-Hospital Mortality Among Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Intensive Care Unit: Retrospective Cohort Study from the eICU Collaborative Research Database.International journal of chronic obstructive pulmonary disease · 2025Article
- DEPTOR attenuates asthma progression by suppressing endoplasmic reticulum stress through SOD1.Biology direct · 2024Article
- Ultrasonographic Assessment of the Diaphragm.Diagnostics (Basel, Switzerland) · 2024Review
- Expiratory flow limitation during mechanical ventilation: real-time detection and physiological subtypes.Critical care (London, England) · 2024Article
- Association Between Acute Kidney Injury During Invasive Mechanical Ventilation and ICU Outcomes and Respiratory System Mechanics.Critical care explorations · 2022Article
- Preemptive Noninvasive Ventilation to Facilitate Weaning from Mechanical Ventilation in Obese Patients at High Risk of Reintubation.American journal of respiratory and critical care medicine · 2022Article
- Three bedside techniques to quantify dynamic pulmonary hyperinflation in mechanically ventilated patients with chronic obstructive pulmonary disease.Annals of intensive care · 2021Article
- A quantitative analysis of extension and distribution of lung injury in COVID-19: a prospective study based on chest computed tomography.Critical care (London, England) · 2021Observational
- Management of Intraoperative Mechanical Ventilation to Prevent Postoperative Complications after General Anesthesia: A Narrative Review.Journal of clinical medicine · 2021Review
- Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study.Frontiers in medicine · 2021Article
- Non-interventional monitoring of expiratory flow limitation during experimental mechanical ventilation.ERJ open research · 2021Article
- Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.Critical care (London, England) · 2020Article
- A Physiological Point of View on Expiratory (Re)action during Mechanical Ventilation.American journal of respiratory and critical care medicine · 2020Article
- Expiratory flow limitation developed in ICU patients: relationship of fluid overload, respiratory mechanics, and outcome.Critical care (London, England) · 2020Article
Corrections and comments
- Commented on by
Authors and funding
10 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExpiratory flow limitation (EFL) is characterised by a markedly reduced expiratory flow insensitive to the expiratory driving pressure. The presence of EFL can influence the respiratory and cardiovascular function and damage the small airways; its occurrence has been demonstrated in different diseases, such as COPD, asthma, obesity, cardiac failure, ARDS, and cystic fibrosis. Our aim was to evaluate the prevalence of EFL in patients requiring mechanical ventilation for acute respiratory failure and to determine the main clinical characteristics, the risk factors and clinical outcome associated with the presence of EFL.
methodsPatients admitted to the intensive care unit (ICU) with an expected length of mechanical ventilation of 72 h were enrolled in this prospective, observational study. Patients were evaluated, within 24 h from ICU admission and for at least 72 h, in terms of respiratory mechanics, presence of EFL through the PEEP test, daily fluid balance and followed for outcome measurements.
resultsAmong the 121 patients enrolled, 37 (31%) exhibited EFL upon admission. Flow-limited patients had higher BMI, history of pulmonary or heart disease, worse respiratory dyspnoea score, higher intrinsic positive end-expiratory pressure, flow and additional resistance. Over the course of the initial 72 h of mechanical ventilation, additional 21 patients (17%) developed EFL. New onset EFL was associated with a more positive cumulative fluid balance at day 3 (103.3 ml/kg) compared to that of patients without EFL (65.8 ml/kg). Flow-limited patients had longer duration of mechanical ventilation, longer ICU length of stay and higher in-ICU mortality.
conclusionsEFL is common among ICU patients and correlates with adverse outcomes. The major determinant for developing EFL in patients during the first 3 days of their ICU stay is a positive fluid balance. Further studies are needed to assess if a restrictive fluid therapy might be associated with a lower incidence of EFL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.